Posizioni attive di Bill Murphy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Stem Pharm, Inc.
 Stem Pharm, Inc. Medical DistributorsDistribution Services Stem Pharm, Inc. is a neurological drug discovery platform company that uses a human-first approach to develop the next-generation of neurologic drugs. The company is based in Madison, WI, a hub for innovative stem cell and biosciences research. The company's proprietary drug discovery platform is based on human 3D neuro-immune organoids that feature microglia and model neuroinflammation, which play a critical role in many neurological diseases. Stem Pharm applies this platform to discover and validate disease targets and therapeutics for its internal programs in epilepsy, neurodegeneration, and brain cancer as well as for its biopharma partners' therapeutic programs. The company was founded in 2015 by William L. Murphy, Connie Lebakken, and the CEO is Steven R. Visuri. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 | - |
| Fondatore | 01/01/2015 | - |
Storia della carriera di Bill Murphy
Statistiche
Distribuzione geografica
| Stati Uniti | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Settori
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Stem Pharm, Inc.
Stem Pharm, Inc. Medical DistributorsDistribution Services Stem Pharm, Inc. is a neurological drug discovery platform company that uses a human-first approach to develop the next-generation of neurologic drugs. The company is based in Madison, WI, a hub for innovative stem cell and biosciences research. The company's proprietary drug discovery platform is based on human 3D neuro-immune organoids that feature microglia and model neuroinflammation, which play a critical role in many neurological diseases. Stem Pharm applies this platform to discover and validate disease targets and therapeutics for its internal programs in epilepsy, neurodegeneration, and brain cancer as well as for its biopharma partners' therapeutic programs. The company was founded in 2015 by William L. Murphy, Connie Lebakken, and the CEO is Steven R. Visuri. | Distribution Services |
- Borsa valori
- Insiders
- Bill Murphy
- Esperienza
